Global Genomics Market

Global Genomics Market Size, Share, Growth Analysis, By Deliverables(Product, Service), By Technology(Sequencing, PCR), By End Use(Government, Academic Institutes), By Application(Drug Discovery & Development, Diagnostics) - Industry Forecast 2024-2031


Report ID: SQMIG35H2173 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 121 | Figures: 77

Global Genomics Market Competitive Landscape

The Global Genomics Market is vast in nature with the presence of major companies in the market using operational strategies to promote their items and develop their market positions. One such strategy is to create new goods in collaboration with other firms in order to broaden their reach to end consumers. In August 2021, Genome Medical Announces the Acquisition of GeneMatters and the Closing of $60 Million Series C Financing.

Genomics Market Top Players Company Profiles

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific (US)
  • Qiagen N.V.
  • BGI Group
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Bio-Rad Laboratories, Inc.
  • Genewiz, Inc.
  • Myriad Genetics, Inc.
  • Fluidigm Corporation
  • PerkinElmer, Inc.
  • Twist Bioscience Corporation
  • Natera, Inc.
  • Veracyte, Inc.
  • Personalis, Inc.
  • 10x Genomics, Inc.

Genomics Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Genomics Market size was valued at USD 27.81 billion in 2019 and is poised to grow from USD 33.25 billion in 2023 to USD 411.35 billion by 2031, growing at a CAGR of 19.4% in the forecast period (2024-2031).

The Global Genomics Market is vast in nature with the presence of major companies in the market using operational strategies to promote their items and develop their market positions. One such strategy is to create new goods in collaboration with other firms in order to broaden their reach to end consumers. In August 2021, Genome Medical Announces the Acquisition of GeneMatters and the Closing of $60 Million Series C Financing. 'Illumina, Inc. (US)', 'Thermo Fisher Scientific (US)', 'Qiagen N.V.', 'BGI Group', 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Pacific Biosciences of California, Inc.', 'Oxford Nanopore Technologies, Ltd.', 'Agilent Technologies, Inc.', 'Eurofins Scientific SE', 'Bio-Rad Laboratories, Inc.', 'Genewiz, Inc.', 'Myriad Genetics, Inc.', 'Fluidigm Corporation', 'PerkinElmer, Inc.', 'Twist Bioscience Corporation', 'Natera, Inc.', 'Veracyte, Inc.', 'Personalis, Inc.', '10x Genomics, Inc.'

Global genomics market is being driven by increased application Next-Generation Sequencing (NGS) which is becoming more widely used in cancer research. Whole-genome sequencing, genome diversity inquiry, metagenomics, epigenetics, the discovery of non-coding RNAs and protein-binding sites, and gene-expression profiling by RNA sequencing are all applications of NGS technologies contributing to capturing the genomics market share.

Switch to a customised Illumina global screening array (GSA) microarray instead of the Illumina OmniExpress chip. The OmniExpress chip from Illumina will be phased out in favour of the GSA chip. As a result, organisations like Ancestry.com will be obliged to convert to the GSA, acquire Thermo Fisher Scientific goods, or implement next-generation sequencing technology if they continue to utilize this equipment.

In 2021, the North American genomics market accounted for the largest revenue share of the worldwide market. The availability of money granted by both the government and firms investigating molecular biology are major drivers driving the North American market. Genomic technology is commonly used in pharmaceutical businesses to create high-class medications like IVT (in-vitro transcribed) mRNA. In addition, numerous important companies in the region provide effective genomics solutions. Due to the increased focus on increasing genetic research and development activities and government on encouraging research in the field of genomics and drastically reduced mass-scale genetic testing costs within the region, Asia-Pacific is expected to see significant growth during the forecast period of 2022 to 2028. Active government backing, particularly in the United Kingdom and England, through research funding and genomic analysis, as well as research and academic institutes, is expected to help the business expand in Europe.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Genomics Market

Product ID: SQMIG35H2173

$5,300
BUY NOW GET FREE SAMPLE